PST May Offer Hope for Hormone-Negative

The Windsor Star reports that Canadian and Indian researchers are collaborating on a study to determine the use of the drug pancratistatin (PST) specifically for hormone-negative breast cancers. PST, made from the Hawaiin spider lily, has been shown in studies to kill cancerous cells while sparing healthy ones. If successful, it will be the first drug for hormone-negative cancers.